Table 2

Results of the univariate analysis of survival (ESPAC-3)

 Risk of mortality
5-FU/leucovorinGemcitabineTotal
GATA 6N=150N=163N=313
High1.001.001.00
Medium1.49 (1.01–2.20)0.97 (0.67–1.39)1.19 (0.91–1.55)
Low1.73 (0.99–3.03)0.99 (0.56–1.72)1.27 (0.86–1.89)
Wald χ2 =5.72, p=0.057Wald χ2 =0.04, p=0.982Wald χ2 =2.38, p=0.304
  • 5-FU, 5-fluorouracil.